Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Withdrawn 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Plasma cell 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Tongue Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 21pembrolizumab 12Cetuximab 12Radiotherapy 11Carboplatin 10Nivolumab 9Radiotherapy, Intensity-Modulated 8Fluorouracil 8durvalumab 5Standard of Care 5epacadostat 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Drug Therapy 4Cyclophosphamide 4X-Rays 3Radiosurgery 3Radiation 3Practice Guidelines as Topic 3Panitumumab 3Gene Expression Profiling 3Docetaxel 3Biopsy 3fluoromisonidazole 2fludarabine 2cemiplimab 2aldesleukin 2Venlafaxine Hydrochloride 2Thyroxine 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Microarray Analysis × Head & Neck × Clear all
NCT01332279 2023-04-04

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Fox Chase Cancer Center

Phase 1 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00899704 2019-01-30

Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer

Alliance for Clinical Trials in Oncology

Withdrawn
Head & Neck

Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡